Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Inmode Ltd INMD

Technology Scientific & Technical Instruments
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.


NDAQ:INMD - Post by User

Inmode Ltd
<< Previous
 Bullboard Posts
User Avatar Image
(291)
•••
Post by whytestockson Oct 14, 2024 12:17am
84 Views
Post# 36264912

Overweight Recommendation Issued On INMD By Barclays

Overweight Recommendation Issued On INMD By Barclays
NEWS: $INMD Overweight Recommendation Issued On INMD By Barclays2024-10-14 00:00:04 ET Barclays analyst issues OVERWEIGHT recommendation for INMD on October 12, 2024 05:23PM ET. The previous analyst recommendation was Overweight. INMD was trading at $16.5 at issue of the analyst recommendation. The overall analyst consensus : HOLD. ...INMD - Overweight Recommendation Issued On INMD By Barclays

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities